Trial design {8}
breast cancer
BREAST CANCER
The trial design is a randomised, prospective superiority trial with an experimental (breathe well) and a control (RPM/RGSC) arm allocation ratio 1:1. Patients receiving radiotherapy for left-sided breast cancer will be randomised into two equal groups. The experimental arm will manage breath holds with audiovisual biofeedback from the Breathe Well device. Patients in the control arm will manage breath holds using an in-house developed audiovisual feedback for the RPM/RGSC system. The trial schema is summarised in Fig. The BRAVEHeart study schema